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Background: The Affordable Care Act requires most private health plans to cover contraceptive methods, services and counseling, without
any out-of-pocket costs to patients; that requirement took effect for millions of Americans in January 2013.
Study design: Data for this study come from a subset of the 1842 women aged 18–39 years who responded to all four waves of a national
longitudinal survey. This analysis focuses on the 892 women who had private health insurance and who used a prescription contraceptive method
during any of the four study periods.Women were asked about the amount they paid out of pocket in an average month for their method of choice.
Results: Between fall 2012 and spring 2014, the proportion of privately insured women paying zero dollars out of pocket for oral
contraceptives increased substantially, from 15% to 67%. Similar changes occurred among privately insured women using injectable
contraception, the vaginal ring and the intrauterine device.
Conclusions: The implementation of the federal contraceptive coverage requirement appears to have had a notable impact on the out-of-
pocket costs paid by privately insured women, and that impact has increased over time.
Implications: This study measures the out-of-pocket costs for women with private insurance prior to the federal contraceptive coverage
requirement and after it took effect; in doing so, it highlights areas of progress in eliminating these costs.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/
licenses/by-nc-sa/3.0/).Keywords: Contraception; Oral contraceptive pills; Insurance; Health reform; Out-of-pocket costs1. Introduction
One high-profile provision of the Affordable Care Act is a
requirement that private health plans cover contraceptive
methods, services and counseling for women, without any
copayments, deductibles or other patient out-of-pocket costs
[1]. This federal contraceptive coverage guarantee— part of
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licenses/by-nc-sa/3.0/).for dozens of recommended preventive care services— was
phased in starting in August 2012 and began affecting health
plans widely in January 2013.
Even before that requirement took effect, coverage of a
wide range of contraceptive methods was standard in U.S.
private health plans [2]. Where the federal requirement broke
new ground, at least for private health plans, was in its
prohibition on patient cost sharing. That change brought with it
the potential to eliminate cost as a reason for choosing one
method of contraception over another, a change that could be
particularly important for low-income women and women
considering methods with substantial upfront costs.
This report provides new, national-level data about the
reach and impact of the contraceptive coverage require-
ment. It utilizes information collected from a longitudinal
survey of women, comparing women's responses in fall
2012, before the contraceptive coverage requirement wouldess article under the CC BY-NC-SA license (http://creativecommons.org/
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three subsequent rounds of the survey (at 6-month intervals)
that were fielded after the requirement was implemented
for millions.
An earlier analysis, using just the first two waves of this
survey (fall 2012 and spring 2013), was published in
December 2013 and found substantial increases in the
proportions of privately insured women paying zero dollars
out of pocket for oral contraceptives and the vaginal ring
over just the first few months of the federal guarantee [3]. An
April 2014 report from the IMS Institute for Healthcare
Informatics found similar trends and estimated that women
saved nearly half a billion dollars in out-of-pocket costs for
contraception in 2013 in the wake of the guarantee [4]. Our
report provides more up-to-date information to bolster this
body of knowledge.1 The previously published article in Contraception reported that 40%
f pill users paid nothing out of pocket during Wave 2. The difference is
ecause the prior study restricted analyses to women who were privately
sured and using the pill at both points in time, while the current study
corporated women who may have experienced changes in insurance
overage or method use. Moreover, respondents included in the earlier
nalyses who failed to participate in subsequent waves are excluded from
e current study.2. Materials and Methods
Data for this analysis come from all four waves of the
Guttmacher Institute's Continuity and Change in Contra-
ceptive Use Study, which surveyed women about their
contraceptive use repeatedly over an 18-month time period.
This analysis is based on the methodology used for the
Guttmacher Institute's first analysis described above [3].
More details on the methodology can be found in that article,
but we provide a brief description below.
The survey was administered online to a national sample
of women aged 18–39 years. It was administered by the
market research firm GfK using their KnowledgePanel, a
national household panel recruited using a probability-based
methodology.
The survey was conducted over 3-week periods in fall
2012, spring 2013, fall 2013 and spring 2014. Of the 4634
women who participated in the baseline study, 3207
participated at Wave 2, 2398 participated at Wave 3 and
1842 participated at Wave 4, resulting in between-survey
response rates of 69%, 75% and 77%, respectively. The
sample for the current analysis was limited to women who
participated in all four waves of the study or 40% of the
baseline sample. The sample used for this analysis was
further limited to women who had private health insurance
and used a prescription contraceptive method during any
of the four study periods (892 women).
In this analysis, we focused on survey questions about
out-of-pocket payments for contraception among women
who used hormonal methods in the last 30 days or obtained
an intrauterine device (IUD) between surveys. We examined
the percentage of women who reported paying nothing, as
well as the mean and median amounts that women paid for
the pill; the number of women paying for methods other than
the pill was too small for an analysis of means and medians.
Women who reported that they used the pill, injectable or
vaginal ring during the last 30 days were asked how much
they paid for the method out of pocket each month. Weassessed change over time in cross-tabulations using Rao-
Scott–corrected χ2 tests in order to include as many women
as possible in all analyses while also taking into account the
clustering of data within individuals. Our focus is change
over time, and χ2 statistics allow us to assess differences
across all waves at once rather than whether specific waves
are statistically different from each other. Our analysis is
based on a total of 1916 observations of pill use, 107
observations of injectable use and 151 observations of ring
use as reported by 892 women; some women contributed up
to four observations per method, while others only
contributed one.
IUD users were only asked about cost the first time they
reported use of the method. Because we captured relatively
few new IUD users covered by private health insurance in
waves two through four (n=45), we used t tests to assess for
differences between the proportions who paid nothing for the
method at Wave 1 compared to the users at Waves 2, 3 and 4
grouped together. Our analysis is based on 165 IUD users.
We did not ask about type of IUD— copper vs. hormonal—
and both are grouped together.
The number of users of the patch and implant were too
small to be reliable; thus, those methods were excluded
from this analysis. Analyses were performed using Stata 13.
All findings presented were statistically significant at the
pb.05 level.3. Results
Among women who reported using the pill and having
private health insurance, the proportion who did not pay
anything out of pocket increased from 15% to 67% between
Waves 1 and 4 (Fig. 1). The most substantial increase
occurred between Wave 1 and Wave 2 (from 15% to 44%1),
but there was a continuing upward trend over the 18-month
time period.
We conducted a sensitivity analysis that examined
changes in out-of-pocket costs when the sample was
restricted to women who were privately insured and using
the pill during all four waves (n=308, obs=1227). The
proportions paying US$0 were virtually the same, 15%,
45%, 57% and 69% (pb.001), respectively (data not shown).
In addition, we also examined these changes when the
sample was restricted to women who were privately insured
and using the pill at both Waves 1 and 4 (n=350). The
proportions paying US$0 were 16% and 69%, and a paired
t test indicated that the difference was significant at pb.001o
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Fig. 1. Percent of privately insured women who paid US$0 out of pocket for their method.
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found in analyses using all available observations.
Similar increases in the proportion paying zero dollars out
of pocket were observed for injectable contraception users
and vaginal ring users with private insurance. For injectable
users, the proportion increased from 27% to 59% between$14.35 
$9.65 $10
$5
$0.00 
$2.00 
$4.00 
$6.00 
$8.00 
$10.00 
$12.00 
$14.00 
$16.00 
Fall 2012
n = 502
Spring 2013
n = 484
Mean M
Fig. 2. Mean and median out-of-pocket costs foWave 1 and Wave 4. For ring users, it increased from 20% to
74% over the same time period.
Among IUD users with private health insurance at Wave
1, 45% indicated that they paid nothing for the method. This
increased to 62% among new users in all three subsequent
waves combined (data not shown).$7.97 
$6.48 
$0 $0
Fall 2013
n = 464
Spring 2014
n = 466
edian
r privately insured women using the pill.
47A. Sonfield et al. / Contraception 91 (2015) 44–48Among privately insured women using the pill, the Wave
1 mean out-of-pocket payment was US$14.35 and the
median was US$10; by Wave 4, this had declined to US
$6.48 and US$0, respectively (Fig. 2).
3.1. Limitations
This study is subject to some limitations. Although our
response rates were comparable to those of other studies
using online administration, only 40% of the baseline sample
participated in all four waves of the study, which
compromises the representativeness of the data. The findings
might be further biased if our respondents differed from the
national population in ways that correlate with contraceptive
use. Nonetheless, the data are still useful because they
serve as one of the only sources of information about trends
in contraceptive copays among the same group of women
over time.
Despite the abovementioned concerns, it is reassuring that
the findings here are similar to prior published research: The
mean (US$14.35) and median (US$10) out-of-pocket
payments for the pill in Wave 1 of our study are almost
identical with the mean (US$15.13) and median (US$10)
out-of-pocket payments from another nationally representa-
tive study carried out before the new federal policy took
effect [5].
Some 45% of baseline IUD users reported that they had paid
US$0 for the method, a higher proportion than reported paying
US$0 for the pill, the ring or the injectable atWave 1. Prior to the
contraceptive coverage guarantee, many women had to pay
several hundred dollars out of pocket for the IUD. One potential
interpretation of the pattern in our data is that many women
unable to obtain the method at no cost were unable to afford it at
all. That is, prior to coverage guarantee, women may have opted
to pay a relatively modest copayment each month for the pill
rather than come up with several hundred dollars to cover out-of-
pocket costs for the IUD.4. Discussion
The findings of this study suggest that the federal contracep-
tive coverage guarantee has had a substantial impact in
eliminating out-of-pocket costs among privately insured women
using some methods of contraception — including oral
contraceptives, the most popular reversible method in the United
States. Between fall 2012 and spring 2014, the proportion of pill
users paying zero dollars out of pocket increased from 15% to
67%, with similar trends for injectable, ring and IUD users.
Further progress may still be expected as more private
health plans become subject to the requirement. Notably,
existing plans are grandfathered — exempt from the
requirement— so long as they make no significant negative
changes, such as benefit reductions or cost sharing increases.
That status is designed to be temporary to allow for a
smoother transition to new federal rules, and the number of
people enrolled in grandfathered plans has been decliningrapidly, from 48% of covered workers in 2012 to 36% in
2013 and 26% in 2014 [6].
However, the proportion of women paying zero dollars
will never reach 100%, for several reasons:
• Federal guidance allows insurers to charge copayments in
limited situations, such as when a woman chooses a brand-
name drug with a generic equivalent or when a woman
receives services from an out-of-network provider [7].
• Federal regulations exempt some employer-sponsored
health plans sponsored by houses of worship from the
contraceptive coverage requirement on religious grounds,
[8] and the U.S. Supreme Court's June 2014 decision in
Burwell v. Hobby Lobby has extended that to certain
closely held for-profit employers.
In addition, several other problems may result in women
paying out of pocket for contraceptive methods despite the
federal guarantee:
• There is evidence that some private health plans are not
adequately complying with what the law clearly
requires — coverage of “the full range” of contracep-
tive methods approved by the Food and Drug
Administration when prescribed for a woman — and
are instead denying coverage, requiring cost sharing or
otherwise restricting access to specific methods [9].
• Other religiously affiliated nonprofits have been
offered an accommodation under which they are
supposed to be absolved from involvement in covering
contraception, but their employees and family mem-
bers must still receive that coverage through the
insurance company [8]. However, there are serious
questions, and a complete dearth of information, about
whether and how plans are complying.
Despite these gaps in the reach of the federal guarantee, the
findings of this study bodewell for the health andwell-being of
women, couples and families. Government bodies and private-
sector experts have long recognized contraceptive services as a
vital and effective component of preventive health care, and an
extensive body of research shows that contraceptive use helps
women avoid unintended pregnancy and improve birth
spacing, resulting in substantial health, social and economic
benefits [10–12]. By guaranteeing that women have coverage
for a wide range of contraceptive choices without cost sharing,
the federal requirement may help them overcome financial
barriers to choosing a contraceptivemethod theywill be able to
use consistently and effectively, thus increasing their likeli-
hood of avoiding unplanned pregnancies.
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